Concepedia

Christine Dentan

CD

5

Publications

416

Citations

5

H-Index

1994

Active since

Affiliations

Inserm(Current)

Christine Dentan is an author at Inserm specializing in drug discovery, medicine, and natural sciences.

Top concepts

Publications per year

1994–1996

5

Publications

5

PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma

Alexandros D. Tselepis, Christine Dentan, Sonia-Athena P. Karabina et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 197 citations · Full text

Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase

Christine Dentan, Alexandros D. Tselepis, M. John Chapman et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1996 · 74 citations

, , +9

Phagocytic Activation Induces Formation of Platelet‐Activating Factor in Human Monocyte‐Derived Macrophages and in Macrophage‐Derived foam Cells

Christine Dentan, Philippe Lesnik, M. John Chapman et al. · European Journal of Biochemistry · 1996 · 61 citations · Full text

PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.

Christine Dentan, Philippe Lesnik, M. John Chapman et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1994 · 52 citations

Tissue Factor Pathway Inhibitor Activity Associated With LDL Is Inactivated by Cell- and Copper-Mediated Oxidation

Philippe Lesnik, Christine Dentan, Alin Vonica et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 32 citations

Rows per page

1–5 of 5